目的系统评价中药四逆散加减对胃食管反流咳嗽(GERC)的临床疗效,旨在从循证医学的角度为临床治疗GERC提供更多证据支持。方法检索中国知网、中国生物医学文献数据库、万方、维普、Pub Med、Web of Science、EMbase中从建库至2020年7月23...目的系统评价中药四逆散加减对胃食管反流咳嗽(GERC)的临床疗效,旨在从循证医学的角度为临床治疗GERC提供更多证据支持。方法检索中国知网、中国生物医学文献数据库、万方、维普、Pub Med、Web of Science、EMbase中从建库至2020年7月23日,关于四逆散加减治疗GERC的随机对照试验(RCTs)。根据纳入和排除标准筛选文献,提取资料后运用Cochrane协作网"偏倚风险"评价文献质量,并使用Rev Man 5.4软件对数据进行统计分析。结果共纳入7篇文献,合计619例患者。Meta分析结果显示:四逆散加减在提高临床有效率[OR=3.15,95%CI(1.88,5.28)],降低IL-8水平[MD=-11.75,95%CI(-14.61,-8.89)]及SP水平[SMD=-1.86,95%CI(-2.17,-1.54)],提高生活质量评分[MD=3.02,95%CI(1.90,4.13)],改善胃镜下疗效[OR=1.90,95%CI(1.06,3.14)]方面优于常规西药。结论四逆散加减对治疗GERC有一定疗效,且未发现不良反应,安全性较高。但现今高证据级别的临床研究相对较少,亟待大量高质量的循证医学研究予以进一步证实。展开更多
OBJECTIVE: To study the therapeutic effects of "soothing the liver method" on stress-related non-alcoholic fatty liver and its treatment mechanism on neuroendocrine-metabolic level. METHODS: The animal model...OBJECTIVE: To study the therapeutic effects of "soothing the liver method" on stress-related non-alcoholic fatty liver and its treatment mechanism on neuroendocrine-metabolic level. METHODS: The animal model of stress-related nonalcoholic fatty liver which is more in line with the modern social and clinical conditions was established by the method of chronic restraint compound high-fat feed. AST and ALT were detected by automatic biochemical analyzer. Serum cortisol and TNF-a were detected by radioimmunoassay. The relative expression of Nr3 c1 mRNA was detected by real-time quantitative PCR. RESULTS: Compared with the blank group, the scores of open field test, Nr3 c1 mRNA decreased, and AST, ALT, FFA were significantly increased in model group. Compared with model group, the open field test scores, Nr3 c1 mRNA increased,and Cor, AST, FFA, LDL, TNF-a, were significantly decreased in SNS group. CONCLUSIONS: "Soothing the liver method" can exert its therapeutic effect on stress-related non-alcoholic fatty liver on neuroendocrine-metabolic level.展开更多
文摘目的系统评价中药四逆散加减对胃食管反流咳嗽(GERC)的临床疗效,旨在从循证医学的角度为临床治疗GERC提供更多证据支持。方法检索中国知网、中国生物医学文献数据库、万方、维普、Pub Med、Web of Science、EMbase中从建库至2020年7月23日,关于四逆散加减治疗GERC的随机对照试验(RCTs)。根据纳入和排除标准筛选文献,提取资料后运用Cochrane协作网"偏倚风险"评价文献质量,并使用Rev Man 5.4软件对数据进行统计分析。结果共纳入7篇文献,合计619例患者。Meta分析结果显示:四逆散加减在提高临床有效率[OR=3.15,95%CI(1.88,5.28)],降低IL-8水平[MD=-11.75,95%CI(-14.61,-8.89)]及SP水平[SMD=-1.86,95%CI(-2.17,-1.54)],提高生活质量评分[MD=3.02,95%CI(1.90,4.13)],改善胃镜下疗效[OR=1.90,95%CI(1.06,3.14)]方面优于常规西药。结论四逆散加减对治疗GERC有一定疗效,且未发现不良反应,安全性较高。但现今高证据级别的临床研究相对较少,亟待大量高质量的循证医学研究予以进一步证实。
文摘OBJECTIVE: To study the therapeutic effects of "soothing the liver method" on stress-related non-alcoholic fatty liver and its treatment mechanism on neuroendocrine-metabolic level. METHODS: The animal model of stress-related nonalcoholic fatty liver which is more in line with the modern social and clinical conditions was established by the method of chronic restraint compound high-fat feed. AST and ALT were detected by automatic biochemical analyzer. Serum cortisol and TNF-a were detected by radioimmunoassay. The relative expression of Nr3 c1 mRNA was detected by real-time quantitative PCR. RESULTS: Compared with the blank group, the scores of open field test, Nr3 c1 mRNA decreased, and AST, ALT, FFA were significantly increased in model group. Compared with model group, the open field test scores, Nr3 c1 mRNA increased,and Cor, AST, FFA, LDL, TNF-a, were significantly decreased in SNS group. CONCLUSIONS: "Soothing the liver method" can exert its therapeutic effect on stress-related non-alcoholic fatty liver on neuroendocrine-metabolic level.
